Fundraising Fox

Holiferm

Founded 2018 Β· 69 employees on LinkedIn Β· 2 known investors

Holiferm develops and produces performance ingredients using biomanufacturing and fermentation, supplying biosurfactants for use in personal care, cosmetics, and household cleaning products. Its ingredients are used by consumer brands in products such as cleansers, shower foams, surface cleaners, and shampoo bars.

Also known as Holiferm Limited

Investors Β· 2

Funding

SEC filings, press & company announcements

Source: company announcements and press reports β€” follow each round's link for the claim.

Company profile

researched Aug 2026

Holiferm is a UK biomanufacturing company that produces performance ingredients, principally biosurfactants, using fermentation. Its molecules β€” including sophorolipids and mannosylerythritol lipids (MELs) β€” are positioned as renewable alternatives to petrochemical surfactants and are aimed at personal care, home care and agriculture applications. The company states its ingredients are manufactured in the UK, are associated with more than 50% less CO2 compared with petrochemicals and more than 50% less energy than traditional fermentation, and it frames a goal of preventing 1 gigaton of CO2 emissions by 2035.

Alongside ingredient supply, Holiferm offers formulation support through a customer support team that works on bespoke and joint formulations, formulation modification, and product testing and results verification. Its published formulation range spans home care (auto dishwash, laundry liquid, hard surface cleaner, toilet cleaner, glass cleaner, car shampoo, pet shampoo) and personal care (shampoo, cleanser, micellar water, moisturiser, face and body lotion, baby balm, facial foam, sun block, toothpaste, liquid eyeshadow, bath bomb). Consumer products made by partner brands using Holiferm ingredients include An'du shampoo and conditioner bars, Lobey makeup remover gel, shower foam, micellar water and eye makeup remover, Biotat tattoo numbing glide, Green Pyramid Biotech vegetable and fruit wash, The Derma Co Tran-Zelaic pigmentation corrector face wash, GMT Beauty anti-acne skin rescue, Cosy Cottage surface cleaner and 28N glycolipid milk cleanser.

Founding story

Holiferm was co-founded by Dr Ben Dolman and Dr James Winterburn and grew out of PhD research at the University of Manchester. In 2017, while a PhD student at Manchester, Dolman was named a finalist in Nouryon's Imagine Chemistry collaborative innovation program for a process using gravity to separate biochemicals as they are produced; the technology was co-invented at the university and subsequently commercialised through the startup, supported by the University of Manchester's innovation ecosystem.

Business model

Holiferm manufactures and supplies biosurfactant ingredients to brand and formulator customers, supported by formulation development, joint-formulation work and product testing services, and by distribution partnerships in additional markets.

Traction

The company operates a kiloton-capacity commercial plant in Birkenhead producing sophorolipids at large scale, employs more than 50 people, and its ingredients appear in commercial products from multiple consumer brands.

Latest developments

Recent company announcements cover joining the BioRevolution Coalition to advance UK biotechnology and sustainable biomanufacturing, a partnership with Adiego Hermanos to bring biosurfactants to the Spanish market, a partnership with Cosy Cottage to develop MELs-based products, and the appointment of Charles Dimmler as CEO to drive international growth following a publicised search.

β–ΈFull profile β€” market position, technology, go-to-market, geography, history

Market position

Holiferm positions its fermentation-derived surfactants as replacements for traditional petrochemical surfactants used in household and personal care products, with a strategy focused on manufacturing a high-volume product at a relatively low price point to lower the overall cost of biosurfactants and enable market penetration. Potential future applications identified include surface coatings and pharmaceuticals.

Technology

Holiferm's process uses yeast fermentation to convert feedstocks such as sugar and vegetable oil into biosurfactants. Its core co-invented technology separates biochemicals by gravity as they are produced, which the founders describe as requiring less energy and no solvents while increasing the output of existing production plants by up to four times. The technology was demonstrated at pilot scale with sophorolipids before scale-up. The company reports more than 50% less energy use than traditional fermentation and more than 50% less CO2 versus petrochemical routes.

Go-to-market

The company markets directly to formulators and brands via sample requests, bespoke formulation support and a published formulation library, and uses regional distribution partners such as Adiego Hermanos for the Spanish market. It also participates in industry bodies including the BioRevolution Coalition.

Personal care and cosmetics brands, home care and cleaning product manufacturers, and agriculture applications; partner brands include An'du, Lobey, Biotat, Green Pyramid Biotech, The Derma Co, GMT Beauty, Cosy Cottage and 28N.

Geography

Headquartered in the UK with an R&D lab at Severnside Trading Estate, Manchester (M17 1WA, Trafford Park) and a commercial plant at Ocean Park, Dock Road, Birkenhead (CH41 1HW). Company news references availability of its LF biosurfactants in the USA and a distribution partnership covering the Spanish market.

History

The company moved from a two-person start-up rooted in university research to an organisation of more than 50 employees, backed by the University of Manchester's innovation ecosystem. Following early funding in 2019 it planned to scale its separation technology from pilot to pre-industrial scale and to demonstrate it with bioproducts beyond sophorolipids. It now operates a kiloton-capacity plant producing sophorolipids at large scale in Birkenhead, with R&D carried out in Trafford Park, Manchester. Company news items report a partnership with Adiego Hermanos for the Spanish market, a partnership with Cosy Cottage on MELs-based products, the appointment of Charles Dimmler as CEO, and membership of the BioRevolution Coalition.

Compiled by commissioned research from 8 cited public sources β€” announcements, filings, and press listed under research sources below.

Key figures

latest reported
Claimed output increase for existing production plantsMar 20194 x
CO2 reduction vs petrochemicalsJan 202550%
EmployeesJan 202550 people
Energy reduction vs traditional fermentationJan 202550%
HeadcountAug 202669
Sophorolipid production capacityJan 2025Kiloton capacity plant in Birkenhead
Stated CO2 emissions prevention targetJan 2025Preventing 1 gigaton of CO2 emissions by 2035

Company-reported or press-reported figures, each dated to when it was claimed β€” not independently audited.

Timeline Β· 7

launches, deals, and filings
Jun 2026
Holiferm joins the BioRevolution Coalition

Holiferm joined the BioRevolution Coalition to advance UK biotechnology and sustainable biomanufacturing.

source β†—

Feb 2026
Charles Dimmler appointed CEO

Holiferm announced Charles Dimmler as new CEO to drive international growth, following an announced search for a new CEO to ready the business for international growth.

source β†—

Feb 2026
Partnership with Adiego Hermanos for the Spanish market

Holiferm partnered with Adiego Hermanos to bring its biosurfactants to the Spanish market.

source β†—

Feb 2026
Partnership with Cosy Cottage to develop MELs-based products

Holiferm and Cosy Cottage partnered to develop products based on mannosylerythritol lipids (MELs).

source β†—

Jan 2026
LF biosurfactants made available in the USA

Company news item announcing that Holiferm's LF biosurfactants are now available in the USA.

source β†—

Mar 2019
Holiferm receives funding from Icos Capital's ICF III fund

Holiferm secured funding from Icos Capital's ICF III fund, a EUR 50 million collaborative venture capital fund managed by Icos in partnership with Nouryon, Royal Cosun and Buhler Group; it was the fund's third investment. The financing was intended to accelerate business and technical scale-up of the company's gravity-based biochemical separation technology.

source β†—

Jan 2017
Co-founder named finalist in Nouryon Imagine Chemistry program

Ben Dolman, then a PhD student at the University of Manchester, was named a finalist in Nouryon's Imagine Chemistry collaborative innovation program for a process that uses gravity to separate biochemicals.

source β†—

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

β–ΈResearch sources Β· 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Holiferm do?
UK biomanufacturer producing fermentation-derived biosurfactants for personal care, home care and agriculture applications.
Who are Holiferm's investors?
Holiferm's investors include Clean Growth Fund, Rhapsody Venture Partners.